| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1402 | 2019 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients OA Cornely, M Bassetti, T Calandra, J Garbino, BJ Kullberg, O Lortholary, ... Clinical Microbiology and Infection 18, 19-37, 2012 | 1301 | 2012 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1274 | 2018 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 728 | 2014 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 470 | 2014 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures M Cuenca‐Estrella, PE Verweij, MC Arendrup, S Arikan‐Akdagli, J Bille, ... Clinical Microbiology and Infection 18, 9-18, 2012 | 463 | 2012 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by … WW Hope, E Castagnola, AH Groll, E Roilides, M Akova, MC Arendrup, ... Clinical Microbiology and Infection 18, 38-52, 2012 | 381 | 2012 |
| Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus JWM Van der Linden, MC Arendrup, A Warris, K Lagrou, H Pelloux, ... Emerging infectious diseases 21 (6), 1041, 2015 | 380 | 2015 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell … AJ Ullmann, M Akova, R Herbrecht, C Viscoli, MC Arendrup, ... Clinical Microbiology and Infection 18, 53-67, 2012 | 375 | 2012 |
| In Vitro Synergy of Caspofungin and Amphotericin B against Aspergillus and Fusarium spp S Arikan, M Lozano-Chiu, V Paetznick, JH Rex Antimicrobial agents and chemotherapy 46 (1), 245-247, 2002 | 353 | 2002 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 317 | 2014 |
| In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus andFusarium Isolates S Arikan, M Lozano-Chiu, V Paetznick, JH Rex Antimicrobial agents and chemotherapy 45 (1), 327-330, 2001 | 269 | 2001 |
| Microdilution Susceptibility Testing of Amphotericin B, Itraconazole, and Voriconazole against Clinical Isolates of Aspergillus and FusariumSpecies S Arikan, M Lozano-Chiu, V Paetznick, S Nangia, JH Rex Journal of clinical microbiology 37 (12), 3946-3951, 1999 | 230 | 1999 |
| Current status of antifungal susceptibility testing methods S Arikan Medical mycology 45 (7), 569-587, 2007 | 204 | 2007 |
| Improvement in the outcome of invasive fusariosis in the last decade M Nucci, KA Marr, M Vehreschild, C De Souza, E Velasco, P Cappellano, ... Clinical Microbiology and Infection 20 (6), 580-585, 2014 | 191 | 2014 |
| Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM … L Klingspor, AM Tortorano, J Peman, B Willinger, P Hamal, B Sendid, ... Clinical Microbiology and Infection 21 (1), 87. e1-87. e10, 2015 | 164 | 2015 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases AJ Ullmann, OA Cornely, JP Donnelly, M Akova, MC Arendrup, ... Clinical Microbiology and Infection 18, 1-8, 2012 | 129 | 2012 |
| How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) MC Arendrup, N Friberg, M Mares, G Kahlmeter, J Meletiadis, J Guinea, ... Clinical Microbiology and Infection 26 (11), 1464-1472, 2020 | 126 | 2020 |
| EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents MC Arendrup, J Meletiadis, JW Mouton, J Guinea, M Cuenca-Estrella, ... Clinical microbiology and infection 22 (6), 571. e1-571. e4, 2016 | 113 | 2016 |
| ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS O Lortholary, G Petrikkos, M Akova, MC Arendrup, S Arikan‐Akdagli, ... Clinical Microbiology and Infection 18, 68-77, 2012 | 112 | 2012 |
